Contact
Subscribe
Knowledge Hub
Modalities
Topics & Trends
CDMO Pricing
State of the Industry
Research
Pharma’s Almanac
Mobile Navigation
Subscribe for the Newsletter
Loading…
STAGING
Loading…
Knowledge Hub
Filter
Filter
Sort By
Newest First
Modalities
Topics
Reset
Mobile Filter Sidebar
1 / 3
mRNA regulations
mRNA Regulatory Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA32
Sep 15, 2026
cell therapy
Survey of Cell Therapy Formats
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA48
Sep 15, 2026
cell therapy
The Expanding Role of Living Cell Treatments
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA47
Sep 15, 2026
history cell therapy
History of Cell Therapies
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA49
Sep 15, 2026
analytics / biologic
Analytical Basics for Biologics
April Stanley, MS MBA
Nice Insight
NI-8-26-MA37
Sep 15, 2026
sterile
Challenges and Innovation in Sterile Manufacturing
April Stanley, MS MBA
Nice Insight
NI-8-26-MA46
Sep 15, 2026
Sterile market
Sterile CDMO Market Expansion and Capacity Trends
April Stanley, MS MBA
Nice Insight
NI-8-26-MA42
Sep 15, 2026
E. coli
Biomanufacturing with E. coli
April Stanley, MS MBA
Nice Insight
NI-8-26-MA9
Sep 15, 2026
mRNA analytics
The mRNA Therapeutics Analytical Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA10
Sep 15, 2026
invesment
The Funding Roller Coaster of 2023-2024
April Stanley, MS MBA
Nice Insight
NI-8-26-MA8
Sep 15, 2026
talent manufacturing
Pharma Layoffs and the Pharmaceutical Industry Outlook: Why Job Cuts Continue Despite Market Growth
April Stanley, MS MBA; David Alvaro, Ph.D.
Nice Insight
NI-9-26-MA53
Sep 4, 2026
talent manufacturing
Global Talent Shortage
April Stanley, MS MBA; Koey Keylon
Nice Insight
NI-9-26-MA52
Sep 4, 2026
mRNA / analytical
The mRNA Therapeutics Analytical Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA3
Aug 28, 2026
cell therapy
Core Analytical Frameworks in Cell Therapy Quality Control
April Stanley, MS MBA
Nice Insight
NI-8-26-MA38
Aug 28, 2026
small molecules
Small Molecule Discovery and Development Trends
David Alvaro, Ph.D.
Pharma's Almanac
NI-8-26-MA50
Aug 28, 2026
antibodies
Key Technologies Used in Manufacturing Antibodies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA11
Aug 28, 2026
OSD
Oral Solid Dose Manufacturing Basics
April Stanley, MS MBA
Nice Insight
NI-8-26-MA12
Aug 28, 2026
Market Drivers
Small Molecule API Manufacturing Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA43
Aug 28, 2026
OSD
Advanced Oral Solid Dose Manufacturing Technologies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA14
Aug 28, 2026
Market Drivers
Market Drivers for Small Molecule Therapeutics
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA39
Aug 27, 2026
1 / 3